TCT-411: Vessel Response of the Low-Dose Paclitaxel-Eluting Coronary Stent System with Biodegradable Coating in de novo Coronary lesions -Results from the PLUS-ONE trial

TCT-267: The PLUS-ONE First-in-Man (FIM)

TCT-267: The PLUS-ONE First-in-Man (FIM) Study: Safety and Efficacy of Low-Dose Paclitaxel and the COBRA-P Drug-Eluting Stent System with a Novel Biodegradable Coating in de novo Coronary Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Safety and efficacy of low-dose paclitax

Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: The PLUS-ONE first-in-man study

✍ Calderas, Carlos; Condado, Jose Francisco; Condado, Jose Antonio; Flores, Alejan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 509 KB

TCT-404: Late Safety and Efficacy of a Z

TCT-404: Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

TCT-360: Comparison of Sirolimus-Eluting

TCT-360: Comparison of Sirolimus-Eluting NEVOTM Stents with Paclitaxeleluting Taxus LieberteTM stents in De Novo Native Coronary Artery Lesions: Intravascular Ultrasound Results From the Reselution I Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Meta-analysis of everolimus-eluting vers

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: Final 3-year results of the SPIRIT clinical trials program (Clinical evaluation of the Xience v everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)

✍ Dangas, George D. (author);Serruys, Patrick W. (author);Kereiakes, Dean J. (auth 📂 Article 📅 2013 🏛 American College of Cardiology 🌐 English ⚖ 522 KB

Meta-analysis of everolimus-eluting vers

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: Final 3-year results of the SPIRIT clinical trials program (Clinical evaluation of the Xience v everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)

✍ Dangas, George D. (author);Serruys, Patrick W. (author);Kereiakes, Dean J. (auth 📂 Article 📅 2013 🏛 American College of Cardiology 🌐 English ⚖ 522 KB